<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01151826</url>
  </required_header>
  <id_info>
    <org_study_id>4714</org_study_id>
    <nct_id>NCT01151826</nct_id>
  </id_info>
  <brief_title>Quantifying Physical and Biochemical Factors That Contribute to Primary Graft Dysfunction After Lung Transplantation</brief_title>
  <official_title>Measurement of Physical and Biochemical Markers of Reperfusion Edema During Primary Graft Dysfunction Following Lung Transplantation. Assessment of Their Diagnosis and Prognosis Values</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Primary graft dysfunction (PGD or lung reperfusion edema) complicates 10 to 20% of lung
      transplantations and leads to severe early and late postoperative complications. Its
      pathophysiology remains unclear but may involve graft ischemia-reperfusion, increased
      vascular permeability, pneumocyte dysfunction and finally alveolar flooding that impair gas
      exchange and blood oxygenation.Its substrate, namely extravascular lung water (EVLW), can now
      be clinically measured with minimally invasive Intensive Care Unit monitors (PiCCO2®, Pulsion
      Medical Systems) that also provides a physical estimate of pulmonary vascular permeability
      (PVPI). Similarly, biochemical correlates of vascular permeability (ICAM-1) and pneumocyte
      dysfunction (RAGE) can now be measured in plasma samples. Our study aims at quantifying
      physical and biochemical markers of PGD and assess their diagnosis and prognosis values.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>July 2010</start_date>
  <completion_date type="Anticipated">August 2012</completion_date>
  <primary_completion_date type="Anticipated">August 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Diagnosis and prognosis values of extravascular lung water (EVLW) and pulmonary vascular permeability index (PVPI).</measure>
    <time_frame>H0 (At started lung transplantation), H6, H12, H24, H48, H72 after lung transplantation</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Diagnosis and prognosis values of receptor for advanced glycation endproducts (RAGE) and intercellular adhesion</measure>
    <time_frame>H0 (At started lung transplantation), H6, H12, H24, H48, H72 after lung transplantation</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">45</enrollment>
  <condition>Primary Graft Dysfunction</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Lung transplant recipients cared for in Surgical Intensive Care Unit in Strasbourg
        University Hospital, France
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Lung transplant recipient

          -  Age &gt; 18 years

          -  Signed informed consent

          -  Social security affiliation

        Exclusion Criteria:

          -  Age&lt;18

          -  Pregnancy or lactation

          -  Contraindication to femoral arterial catheterization

          -  Patient refusal
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Julien Pottecher, MD</last_name>
    <role>Study Director</role>
    <affiliation>Service d'Anesthésie-Réanimations chirurgicales - Nouvel Hôpital Civil - Hôpitaux Universitaires de Strasbourg Strasbourg, France</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Julien Pottecher, MD</last_name>
    <phone>33 3 69 55 04 44</phone>
    <email>julien.pottecher@chru-strasbourg.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Service de Chirurgie thoracique - Nouvel Hôpital Civil - 1, Place de l'hôpital</name>
      <address>
        <city>Strasbourg Cedex</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gilbert MASSARD, MD</last_name>
      <phone>33 3 69 55 07 98</phone>
      <email>Gilbert.Massard@chru-strasbourg.fr</email>
    </contact>
    <investigator>
      <last_name>Gilbert MASSARD, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pierre-Emmanuel FALCOZ, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nicola SANTELMO, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Service de Physiologie et d'Explorations fonctionnelles - Nouvel Hôpital Civil - 1, Place de l'hôpital</name>
      <address>
        <city>Strasbourg Cedex</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bernard GENY, MD</last_name>
      <phone>33 3 69 55 08 79</phone>
      <email>Bernard.Geny@chru-strasbourg.fr</email>
    </contact>
    <investigator>
      <last_name>Bernard GENY, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Anne CHARLOUX, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Service de Pneumologie - Nouvel Hôpital Civil -1, Place de l'hôpital</name>
      <address>
        <city>Strasbourg Cedex</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Romain KESSLER, MD</last_name>
      <phone>33 3 69 55 06 45</phone>
      <email>Romain.Kessler@chru-strasbourg.fr</email>
    </contact>
    <investigator>
      <last_name>Romain Kessler, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Armelle SCHULLER, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Matthieu CANUET, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sandrine HIRSCHI, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Service d'Anesthésie-Réanimations chirurgicales - Nouvel Hôpital Civil - Hôpitaux Universitaires de Strasbourg</name>
      <address>
        <city>Strasbourg</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julien Pottecher, MD</last_name>
      <phone>33 3 69 55 04 44</phone>
      <email>julien.pottecher@chru-strasbourg.fr</email>
    </contact>
    <investigator>
      <last_name>Julien Pottecher, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jean-Pierre DUPEYRON, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Olivier HELMS, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jean-Gustave HENTZ, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>François LEVY, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jean-Claude RIGOLOT, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Anne-Claude ROCHE, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Régine CUNY, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marie-Odile LEBOUBE, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 25, 2010</study_first_submitted>
  <study_first_submitted_qc>June 25, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 28, 2010</study_first_posted>
  <last_update_submitted>March 1, 2011</last_update_submitted>
  <last_update_submitted_qc>March 1, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 2, 2011</last_update_posted>
  <responsible_party>
    <name_title>Christine GEILLER, directeur de la Direction de la Recherche Clinique et des Innovations</name_title>
    <organization>University Hospital, Strasbourg, France</organization>
  </responsible_party>
  <keyword>Lung transplantation</keyword>
  <keyword>Primary Graft Dysfunction</keyword>
  <keyword>Extravascular Lung Water</keyword>
  <keyword>Receptor for Advanced Glycation Endproducts (RAGE)</keyword>
  <keyword>Intercellular Adhesion Molecule-1 (ICAM-1)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Primary Graft Dysfunction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

